Published in Cancer Weekly, September 20th, 2005
Pharmaceutical researchers in Atlanta conducted a study "to demonstrate the iontophoretic delivery of granisetron hydrochloride by novel, self-contained iontophoretic patches and to determine the subcutaneous and dermal absorption kinetics using microdialysis."
"In vitro iontophoretic delivery of granisetron hydrochloride was evaluated at 5, 10, or 20 mg/mL concentrations of donor using Franz diffusion cells and hairless rat skin as a membrane," explained A. Chaturvedula and coauthors at Mercer University. "In vivo studies were performed in hairless...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.